Detalles de la búsqueda
1.
Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor Method.
Drug Metab Dispos
; 51(9): 1089-1104, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137718
2.
In Vitro Evaluation of the Drug Interaction Potential of Doravirine.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745395
3.
The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?
Drug Metab Dispos
; 44(9): 1498-509, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26825641
4.
Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Antimicrob Agents Chemother
; 58(3): 1294-301, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295974
5.
In Vitro Assessment of Transporter Mediated Perpetrator DDIs for Several Hepatitis C Virus Direct-Acting Antiviral Drugs and Prediction of DDIs with Statins Using Static Models.
AAPS J
; 24(3): 45, 2022 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314909
6.
Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.
J Pharm Sci
; 106(9): 2357-2367, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28416420
7.
Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein.
J Pharmacol Exp Ther
; 321(2): 673-83, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17314201
Resultados
1 -
7
de 7
1
Próxima >
>>